Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Shares Issued (2022 - 2025)

Prokidney (PROK) has disclosed Shares Issued for 3 consecutive years, with $23.4 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 116.22% to $23.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$115.5 million through Dec 2025, up 17.35% year-over-year, with the annual reading at $24.2 million for FY2025, 17219.29% up from the prior year.
  • Shares Issued for Q4 2025 was $23.4 million at Prokidney, up from $854000.0 in the prior quarter.
  • The five-year high for Shares Issued was $23.4 million in Q4 2025, with the low at -$542.5 million in Q4 2022.
  • Average Shares Issued over 3 years is -$131.6 million, with a median of $854000.0 recorded in 2025.
  • Peak annual rise in Shares Issued hit 116.22% in 2025, while the deepest fall reached 80.89% in 2025.
  • Over 3 years, Shares Issued stood at -$542.5 million in 2022, then soared by 73.42% to -$144.2 million in 2024, then skyrocketed by 116.22% to $23.4 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $23.4 million, $854000.0, and -$144.2 million for Q4 2025, Q3 2025, and Q4 2024 respectively.